IL162133A0 - Method of increasing protein expression, proteins and polynucleotides - Google Patents

Method of increasing protein expression, proteins and polynucleotides

Info

Publication number
IL162133A0
IL162133A0 IL16213302A IL16213302A IL162133A0 IL 162133 A0 IL162133 A0 IL 162133A0 IL 16213302 A IL16213302 A IL 16213302A IL 16213302 A IL16213302 A IL 16213302A IL 162133 A0 IL162133 A0 IL 162133A0
Authority
IL
Israel
Prior art keywords
amino acid
polynucleotides
proline
protein expression
proteins
Prior art date
Application number
IL16213302A
Other languages
English (en)
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of IL162133A0 publication Critical patent/IL162133A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/14Lymphokine; related peptides
    • Y10S930/144Tumor necrosis factor

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
IL16213302A 2001-11-30 2002-11-21 Method of increasing protein expression, proteins and polynucleotides IL162133A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34064801P 2001-11-30 2001-11-30
PCT/EP2002/013059 WO2003046160A2 (en) 2001-11-30 2002-11-21 Methods of increasing protein expression levels

Publications (1)

Publication Number Publication Date
IL162133A0 true IL162133A0 (en) 2005-11-20

Family

ID=23334343

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16213302A IL162133A0 (en) 2001-11-30 2002-11-21 Method of increasing protein expression, proteins and polynucleotides

Country Status (12)

Country Link
US (2) US7258997B2 (cg-RX-API-DMAC7.html)
EP (1) EP1448772B1 (cg-RX-API-DMAC7.html)
JP (1) JP2005535281A (cg-RX-API-DMAC7.html)
AT (1) ATE367438T1 (cg-RX-API-DMAC7.html)
AU (1) AU2002338947B2 (cg-RX-API-DMAC7.html)
CA (1) CA2466298A1 (cg-RX-API-DMAC7.html)
DE (1) DE60221273D1 (cg-RX-API-DMAC7.html)
DK (1) DK1448772T3 (cg-RX-API-DMAC7.html)
ES (1) ES2290337T3 (cg-RX-API-DMAC7.html)
IL (1) IL162133A0 (cg-RX-API-DMAC7.html)
PT (1) PT1448772E (cg-RX-API-DMAC7.html)
WO (1) WO2003046160A2 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL162133A0 (en) * 2001-11-30 2005-11-20 Applied Research Systems Method of increasing protein expression, proteins and polynucleotides
US20070099266A1 (en) * 2003-12-23 2007-05-03 Applied Research Systems Ars Holding N.V. Process for the production of tumor necrosis factor-binding proteins
US8722348B2 (en) 2008-05-28 2014-05-13 Wayne State University Method and composition for a protein transduction technology and its applications
US9816076B2 (en) 2011-05-02 2017-11-14 Wayne State University Protein-induced pluripotent cell technology and uses thereof
US10076574B2 (en) 2013-10-25 2018-09-18 Wayne State University Methods, systems and compositions relating to cell conversion via protein-induced in-vivo cell reprogramming
EP3987028A4 (en) * 2019-06-21 2023-07-19 Kernal Biologics, Inc. MODIFIED ONCOSELECTIVE PROTEIN EXPRESSION
CA3169961A1 (en) * 2020-02-03 2021-08-12 Premas Biotech Private Limited Recombinant expression platform, constructs and methods for expression of difficult to express proteins (dte-ps)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59010941D1 (de) * 1989-04-21 2005-03-24 Amgen Inc TNF-Rezeptor, TNF bindende Proteine und dafür kodierende DNAs
EP0614353A1 (en) * 1991-11-25 1994-09-14 Richardson-Vicks, Inc. Compositions for regulating skin wrinkles and/or skin atrophy
IL107268A0 (en) * 1993-10-12 1994-01-25 Yeda Res & Dev Molecules influencing the shedding of the tnf receptor, their preparation and their use
IL159015A0 (en) * 2001-05-25 2004-05-12 Genset Sa Polypeptides, their preparation and use
IL162133A0 (en) * 2001-11-30 2005-11-20 Applied Research Systems Method of increasing protein expression, proteins and polynucleotides

Also Published As

Publication number Publication date
WO2003046160A2 (en) 2003-06-05
WO2003046160A3 (en) 2003-07-31
JP2005535281A (ja) 2005-11-24
ES2290337T3 (es) 2008-02-16
EP1448772B1 (en) 2007-07-18
US20050074840A1 (en) 2005-04-07
ATE367438T1 (de) 2007-08-15
PT1448772E (pt) 2007-10-02
DE60221273D1 (de) 2007-08-30
AU2002338947A1 (en) 2003-06-10
DK1448772T3 (da) 2007-11-19
US20080014635A1 (en) 2008-01-17
CA2466298A1 (en) 2003-06-05
US7258997B2 (en) 2007-08-21
AU2002338947B2 (en) 2007-09-13
EP1448772A2 (en) 2004-08-25

Similar Documents

Publication Publication Date Title
WO2002002627A3 (en) Interferon-like protein zcyto21
EA199900939A1 (ru) Остеопротегерин-связывающие белки и рецепторы
EP1373301A4 (en) WEAKNESS OF IMMUNOGENICITY OF FUSION PROTEINS
DE60323210D1 (en) Eukaryontische signalsequenzen für polypeptid-expr
IL184112A0 (en) A method for producing polypeptides or proteins in a disulfide-bridged two-chain form
WO2002103024A3 (en) Stabilized proteins with engineered disulfide bonds
WO2002060951A3 (en) Methods and compositions for reducing heparan sulfate proteoglycan-mediated clearance of factor viii
UA97628C2 (ru) Способ получения fc-фрагмента иммуноглобулина, свободного от начального метионинового остатка, в массовом масштабе
WO2000071714A3 (en) Methods of reducing factor viii clearance and compositions therefor
EP0965637A4 (en) Fas ANTIGEN DERIVATIVES
SG166117A1 (en) Methods and compositions for treatment of interferon-resistant tumors
DE60335726D1 (de) Chromoprotein und fluoroproteine
DE69827262D1 (de) Penaeidine: antimikrobielle peptide aus krebstieren
IL162133A0 (en) Method of increasing protein expression, proteins and polynucleotides
DK1098972T3 (da) Protein med lighed med neuroendokrinspecifikt protein samt cDNA kodende derfor
PE20020857A1 (es) Proteinas de fusion cuya parte del n-terminal es un derivado de hirudina para la produccion de proteinas recombinantes a traves de la secresion por levaduras
DE60118359D1 (de) Humanische pellino-polypeptide
NO971508L (no) Analoger av sur fibroblastvekstfaktor med forökt stabilitet og biologisk aktivitet
AU2676399A (en) Novel cystine knot protein and materials and methods for making it
JP2005535281A5 (cg-RX-API-DMAC7.html)
NO992531L (no) Fremgangsmåter ved fremstilling av rekombinant protein
EP0750040A3 (en) Macrophage stimulating protein variant and method for producing the same
EP1627063A4 (en) INDUCTION OF FLOWER
WO2003072733A3 (en) Modified bace
WO2003044159A9 (en) Zinc finger proteins, polynucleotides encoding same and antibodies thereto